{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:23:53Z","timestamp":1791267833623,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.autrev.2010.07.018","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T06:43:04Z","timestamp":1280817784000},"page":"835-839","source":"Crossref","is-referenced-by-count":63,"title":["The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases"],"prefix":"10.1016","volume":"9","author":[{"given":"Fabiola","family":"Atzeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Turiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cavagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2010.07.018_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.autrev.2010.07.018_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2010.06.001","article-title":"How early is the atherosclerotic risk in rheumatoid arthritis?","author":"Bartoloni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.07.018_bb0015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2010.07.018_bb0020","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.23526","article-title":"Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal","volume":"59","author":"Alacqua","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1258\/jrsm.99.3.132","article-title":"Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis","volume":"99","author":"Caldwell","year":"2006","journal-title":"J R Soc Med"},{"key":"10.1016\/j.autrev.2010.07.018_bb0030","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.pctr.0010033","article-title":"Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)","volume":"1","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"10.1016\/j.autrev.2010.07.018_bb0035","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/ard.2007.087254","article-title":"The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs","volume":"68","author":"van der Linden","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2010.07.018_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinternmed.2008.525","article-title":"Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure","volume":"169","author":"Gislason","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2010.07.018_bb0045","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.23911","article-title":"Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups","volume":"59","author":"Solomon","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar2471","article-title":"Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis","volume":"10","author":"Hahn","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"S1","key":"10.1016\/j.autrev.2010.07.018_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semarthrit.2005.02.004","article-title":"Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists","volume":"35","author":"Caporali","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1191\/0961203305lu2221oa","article-title":"Cardiovascular effects of coxibs","volume":"14","author":"Caporali","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2010.07.018_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2010.02.009","article-title":"Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review","author":"Ruyssen-Witrand","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2010.07.018_bb0070","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/art.23811","article-title":"The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis","volume":"58","author":"Wolfe","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0075","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0080","article-title":"Daily and cumulative threshold glucocorticoid dose associated with cardiovascular and all-cause mortality in rheumatoid arthritis","volume":"56","author":"del Rincon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0090","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.ATV.0000038754.39483.CD","article-title":"Unraveling pleiotropic effects of statins on plaque rupture","volume":"22","author":"Palinski","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.autrev.2010.07.018_bb0095","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2010.07.018_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.autrev.2010.07.018_bb0105","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(00)02222-4","article-title":"Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity","volume":"355","author":"Landewe","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2010.07.018_bb0110","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2010.07.018_bb0115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keh610","article-title":"Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis","volume":"44","author":"Bernatsky","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2010.07.018_bb0120","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2010.07.018_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.61.6.567","article-title":"Leflunomide and hypertension","volume":"61","author":"Rozman","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2010.07.018_bb0130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.22094","article-title":"Antirheumatic drug use and the risk of acute myocardial infarction","volume":"55","author":"Suissa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0135","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/art.22255","article-title":"Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis","volume":"54","author":"Solomon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.07.018_bb0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study","volume":"113","author":"Park","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2010.07.018_bb0145","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment \u2014 a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2010.07.018_bb0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2010.07.018_bb0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.autrev.2010.07.018_bb0160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard.2006.063867","article-title":"What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology","volume":"66","author":"Dixon","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.autrev.2010.07.018_bb0165","first-page":"83","article-title":"Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol."},{"issue":"106","key":"10.1016\/j.autrev.2010.07.018_bb0170","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"22","author":"H\u00fcrlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2010.07.018_bb0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.20407","article-title":"Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody","volume":"51","author":"Gonzalez-Juanatey","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2010.07.018_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/03009740802363768","article-title":"Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients","volume":"38","author":"Sidiropoulos","year":"2009","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.autrev.2010.07.018_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-5922.2009.00119.x","article-title":"Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis","author":"Turiel","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.autrev.2010.07.018_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2004.09.004","article-title":"TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma","volume":"4","author":"Sarzi-Puttini","year":"2005","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.autrev.2010.07.018_bb0195","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/art.24308","article-title":"Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy","volume":"59","author":"Gonzalez-Juanatey","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2010.07.018_bb0200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.autrev.2009.03.010","article-title":"Prospective new biological therapies for rheumatoid arthritis","volume":"9","author":"Senolt","year":"2009","journal-title":"Autoimmun Rev."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T21:54:57Z","timestamp":1544306097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997210001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1568997210001564"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2010.07.018","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}